Fusion Pharmaceuticals In... (FUSN)
Fusion Pharmaceuticals Max Pain By Strike
FUSN trades at $21.55, 77.3% below the near-term max pain of $95 expiring Jan 16, 2026 (154 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is stable across expirations ($5-$95), indicating stable market expectations. High dispersion in max pain levels suggests competing forces and potential volatility.
Fusion Pharmaceuticals Max Pain By Expiry
Max pain for FUSN shows stable levels around 50.00, reflecting balanced market expectations. The 180% spread signals divergent expectations across timeframes. Levels distributed around 21.55. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Jan 16, 2026 | 95 | 73.45 (340.84%) |
| Feb 20, 2026 | 5 | -16.55 (-76.80%) |